Insulin Markets in Europe to 2022 - Market Size, Development, and Forecasts

Publisher Name :
Date: 08-Jan-2018
No. of pages: 608
Inquire Before Buying

The industry report package Insulin Markets in Europe to 2022 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for insulin in different European countries. The package includes insulin country reports from the following countries:

Armenia, Austria, Azerbaijan, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Macedonia, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovakia, Slovenia, Spain, Sweden, Turkey, Ukraine, United Kingdom

The reports include historic market data from 2011 to 2017 and forecasts until 2022 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key industry data in readily accessible and clearly presented tables and graphs.

The latest market data for this research include:

  • Overall insulin market size, 2011-2022

  • Insulin market size by product segment, 2011-2022

  • Growth rates of the overall insulin market and different product segments, 2011-2022

  • Shares of different product segments of the overall insulin market, 2011, 2017 and 2022

The product segments discussed in the data reports include:

  • Bulk insulin

  • Dosage insulin

The reports help answering the following questions:

  • What is the current size of the insulin market in different European countries?

  • How is the insulin market divided into different product segments?

  • How are the overall market and different product segments growing?

  • How is the market predicted to develop in the future?

  • What is the market potential compared to other countries?

Among the key reasons to purchase include the following:

  • Gain an outlook of the historic development, current market situation, and future outlook of the insulin market in different European countries to 2022

  • Track industry development and identify market opportunities

  • Plan and develop marketing, market-entry, market expansion, and other business strategies by identifying the key market opportunities and prospects

  • Save time and money with the readily accessible key market data included in the report. The market data is clearly presented and can be easily incorporated into presentations, internal reports, etc.

Insulin Markets in Europe to 2022 - Market Size, Development, and Forecasts

Table of Contents

This industry report package includes country reports from the following countries:

Armenia, Austria, Azerbaijan, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Macedonia, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovakia, Slovenia, Spain, Sweden, Turkey, Ukraine, United Kingdom

Below you can find the table of contents for one of the reports. All the reports have a similar structure and content so that different countries can be easily compared with each other.

1. Market for Insulin in the Country in Question 6
Overall Market 6
Market by Type 7
Bulk insulin 8
Dosage insulin 9

2. Forecasts and Future Outlook 10
Overall Market 10
Market by Type 11
Bulk insulin 12
Dosage insulin 13

3. Market Definition 16

4. Methodology and Sources 17

5. About Global Research & Data Services 18

List of Tables

Table 1 Demand for insulin in the country in question, 2011-2017 (US dollars)
Table 2 Demand for insulin in the country in question, by type, 2008 and 2014 (share)
Table 3 Demand for bulk insulin in the country in question, 2011-2017 (US dollars)
Table 4 Demand for dosage insulin in the country in question, 2011-2017 (US dollars)
Table 5 Demand for insulin in the country in question, 2017-2022 (US dollars)
Table 6 Demand for insulin in the country in question, by type, 2011, 2017 and 2022 (share)
Table 7 Demand for bulk insulin in the country in question, 2017-2022 (US dollars)
Table 8 Demand for dosage insulin in the country in question, 2017-2022 (US dollars)

List of Graphs

Graph 1 Demand for insulin in the country in question, 2011-2017 (US dollars)
Graph 2 Demand for bulk insulin in the country in question, 2011-2017 (US dollars)
Graph 3 Demand for dosage insulin in the country in question, 2011-2017 (US dollars)
Graph 3 Demand for insulin in the country in question, 2011-2022 (US dollars)
Graph 4 Demand for bulk insulin in the country in question, 2011-2022 (US dollars)
Graph 5 Demand for dosage insulin in the country in question, 2011-2022 (US dollars)
  • Global Insulin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Jun-2018        Price: US 3480 Onwards        Pages: 136
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. Scope of the Report: This rep......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin Market 2018, Forecast to 2023
    Published: 12-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. Scope of the Report: This rep......
  • Global Insulin API Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Jun-2018        Price: US 3480 Onwards        Pages: 131
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal i......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin API Market 2018, Forecast to 2023
    Published: 12-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal i......
  • Global Liraglutide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Jun-2018        Price: US 3480 Onwards        Pages: 137
    Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition. ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Liraglutide Market 2018, Forecast to 2023
    Published: 11-Jun-2018        Price: US 4880 Onwards        Pages: 134
    Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition. ......
  • Global Diabetes Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 06-Jun-2018        Price: US 3480 Onwards        Pages: 149
    Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that's made by an organ called the pancreas. When the body doesn't make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems - including blindness, kidney damage, heart disease and stroke. That's why it's important to take medicine that helps l......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Diabetes Drugs Market 2018, Forecast to 2023
    Published: 06-Jun-2018        Price: US 4880 Onwards        Pages: 148
    Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that's made by an organ called the pancreas. When the body doesn't make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems - including blindness, kidney damage, heart disease and stroke. That's why it's important to take medicine that helps l......
  • China Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2018
    Published: 31-May-2018        Price: US 3400 Onwards        Pages: 96
    The global Glucagon Like Peptide-1 (GLP-1) Agonists market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Glucagon Like Peptide-1 (GLP-1) Agonists development status and future trend in China, focuses o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs